Device for the determination of glycated hemoglobin

• US 8,206,563 B2
• Filed: 12/06/2005
• Issued: 06/26/2012
• Est. Priority Date: 05/16/2001
• Status: Expired due to Fees

• Current Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories Incorporated)
• Inventors: Heller, Adam
• Primary Examiner(s): Noguerola, Alex
• Assistant Examiner(s): Kaur, Gurpreet
• Application Number:
  US11/296,183
• Publication Number:
  US 20060205029A1
• Time in Patent Office: 2,394 Days
• Field of Search: 204/403.01, 204/403.14, 205/777.5, 205/792, 435/25, 435/14, 435/287.1, 435/7.9
• US Class Current: 204/403.01
• CPC Class Codes: C12Q 1/26 involving oxidoreductase
• CPC Class Codes: F01B 1/12 Separate cylinder-crankcase elements coupled together to form a unit
• CPC Class Codes: F01L 9/20 by electric means
• CPC Class Codes: F02B 75/20 with cylinders all in one line
• CPC Class Codes: G01N 2333/805 Haemoglobins; Myoglobins
• CPC Class Codes: G01N 33/723 Glycosylated haemoglobin
• CPC Class Codes: H01M 8/16 Biochemical fuel cells, i.e. cells in which microorganisms function as catalysts
• CPC Class Codes: Y02E 60/50 Fuel cells

Abstract

A method of determining the percentage of glycated hemoglobin in a blood sample is disclosed wherein at least one of the assay steps is performed electrochemically. The method includes determining the total amount of hemoglobin in a sample by electrochemically measuring, in an oxygen electroreduction reaction at a cathode, the amount of oxygen in the sample. Because the amount of oxygen dissolved in the sample is known, the total hemoglobin is determined by subtracting the amount of free oxygen from the total oxygen measured, recognizing the fast equilibrium Hb+O₂⇄HbO₂. This can be followed by determining the amount of glycated hemoglobin in the sample. The cathode reaction is accomplished by contacting the sample with an enzyme, the enzyme being a copper-containing enzyme having four copper ions per active unit. The family of these enzymes includes, for example, laccases and bilirubin oxidases. A device associated with such a process or method is also provided.

Claims

1. A device for use in electrochemically assaying glycated hemoglobin in a blood, blood-containing, or blood-derived sample, comprising:

a first chamber and a second chamber separate from the first chamber, wherein the first and second chambers comprise;

a cathode comprising an enzyme capable of reducing oxygen to water and a redox mediator, wherein the enzyme and the redox mediator are immobilized on the cathode by a polymer, wherein the redox mediator and the polymer form a redox polymer, and an anode, and

wherein the second chamber further comprises a surface-immobilized glycated hemoglobin separating agent or a glycated hemoglobin hydrolysis agent.

2. The device of claim 1, wherein the enzyme is a four copper-ion containing copper enzyme.

3. The device of claim 2, wherein the four copper-ion containing copper enzyme is selected from a laccase, a bilirubin oxidase, ceruloplasmin and ascorbate oxidase.

4. The device of claim 3, wherein the enzyme is a bilirubin oxidase.

5. The device of claim 4, wherein the redox polymer is polyacrylamide-poly(n-vinylimidazole)-[Os(4,4′

-dichloro-2,2′

-bipyridine)₂Cl]^+/2 (PAA-PVI-[Os(4,4′

-dichloro-2,2′

-bipyridine)₂Cl]^+/2+).

6. The device of claim 1 comprising a glycated hemoglobin hydrolysis agent.

7. The device of claim 6, wherein the glycated hemoglobin hydrolysis agent is a proteolytic enzyme.

8. The device of claim 7, comprising an enzyme that oxidizes ketoamines.

9. The device of claim 8, wherein the enzyme that oxidizes ketoamines is selected from a fructosamine oxidase and a four copper-ion containing copper enzyme.

10. The device of claim 9, further comprising a redox mediator.

11. The device of claim 10, wherein the redox mediator is an Os^2+/3+ or Ru²⁺³⁺ complex.

12. The device of claim 1 comprising a surface-immobilized glycated hemoglobin separating agent.

13. The device of claim 12, wherein the separating agent is selected from an anti-glycated hemoglobin antibody and a boronic acid-modified surface.

14. The device of claim 13, wherein the boronic acid modified surface is selected from magnetic, polymer or glass beads.

15. The device of claim 12, further comprising an enzyme that oxidizes fructosyl amines.

16. The device of claim 15, wherein the enzyme is selected from a fructosyl amine oxidase or a four copper-ion containing copper enzyme.

17. The device of claim 12, further comprising an cross-linked polyN-vinyl imidazole based redox polymer film.

18. The device of claim 12, further comprising a glycated hemoglobin hydrolysis agent.

19. The device of claim 18, wherein the glycated hemoglobin hydrolysis agent is a proteolytic enzyme.

20. The device of claim 19, further comprising an enzyme that oxidizes ketoamines.

21. The device of claim 20, wherein the enzyme that oxidizes ketoamines is selected from a fructosamine oxidase and a four copper ion containing copper enzyme.